Medication info
Arenmax Tablets (Sodium Alendronate Trihydrate)

Arenmax Tablets (Sodium Alendronate Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Trihydrate›91.37mg / 1 tablet
Manufacturer / importer
Yuyoung Pharmaceutical Co., Ltd.
Appearance
White oval-shaped tablet
Packaging
4 tablets (4 tablets/PTP packaging (AluAlu)x1)
Approval status
Active

MFDS item code 200502717 · Notified 2005.11.21 · Insurance code 648200960

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults
Adult dose
○ Take 70 mg of alendronic acid once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). ○ Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of this medicine (see Interactions). Consuming food within 30 minutes after taking this medicine or at the same time may reduce its absorption into the body and diminish its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients with inadequate dietary calcium and vitamin D intake should take supplements (see Precautions). ○ The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reviewed regularly in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should have their fracture risk reassessed regularly. ○ If you forget to take this medicine on the scheduled day, take 70 mg the following morning, then resume taking it on the originally scheduled day and continue regularly once weekly thereafter. Do not take 2 tablets on the same day.

Ingredients

Manufacturer
Yuyoung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medicine is used for the treatment of osteoporosis in both postmenopausal women and men. Osteoporosis is a condition where the strength of bones decreases, increasing the risk of fractures, and this medication helps strengthen bones to maintain a healthy skeleton. Therefore, it is effective for the treatment of osteoporosis in both postmenopausal women and men.

How to take

Adult dose

○ Take 70 mg of alendronic acid once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). ○ Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of this medicine (see Interactions). Consuming food within 30 minutes after taking this medicine or at the same time may reduce its absorption into the body and diminish its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients with inadequate dietary calcium and vitamin D intake should take supplements (see Precautions). ○ The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reviewed regularly in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should have their fracture risk reassessed regularly. ○ If you forget to take this medicine on the scheduled day, take 70 mg the following morning, then resume taking it on the originally scheduled day and continue regularly once weekly thereafter. Do not take 2 tablets on the same day.

Precautions

This medication may irritate the gastrointestinal mucosa, so patients with esophageal diseases, gastritis, duodenitis, ulcers, etc., should use it with caution. If symptoms such as difficulty swallowing, pain behind the sternum, or heartburn occur after taking the medication, it should be stopped immediately and a doctor should be consulted. Take this medication with a sufficient amount of water, and do not lie down for at least 30 minutes after taking it. The method of administration must be followed accurately. Patients with esophageal abnormalities, hypocalcemia, severe renal failure, pregnant or nursing women, and those with certain genetic disorders should not take this medication. During treatment, it is recommended to ensure adequate calcium and vitamin D intake, as well as maintain weight-bearing exercise and a healthy lifestyle. This medication can cause side effects such as dyspepsia, abdominal pain, nausea, constipation, diarrhea, musculoskeletal pain, headache, etc., so if severe abnormal symptoms occur, inform your doctor. Also, caution should be taken as gastrointestinal irritation may increase when taken with non-steroidal anti-inflammatory drugs or aspirin. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication, and safety in children or adolescents under 18 years has not been established. Elderly patients can also use it, but sensitivity to the drug may vary by individual, so caution is necessary. In case of overdose, hypocalcemia, gastrointestinal irritation, etc., may occur, so strictly adhere to the dosage and seek medical attention immediately if abnormal symptoms develop. This medication should be stored out of reach of children, and it is advisable not to transfer it to other containers.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, hemorrhage, gastric ulcer, duodenal ulcer, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, dysphagia, abdominal distension, gastritis, musculoskeletal pain, muscle cramps, headache, dizziness, taste abnormalities, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, osteonecrosis of the jaw, joint edema, low-energy fractures of the femoral neck and other bones, dizziness, itching, hair loss, mucocutaneous syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent moisture ingress, and it is best kept in a cool place between 15 and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained for a longer period.

Appearance and packaging

Appearance

White oval-shaped tablet

Package unit

4 tablets (4 tablets/PTP packaging (AluAlu)x1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.